Very low frequency power of heart rate variability is a powerful predictor of clinical prognosis in patients with congestive heart failure.

BACKGROUND The present study examined whether the very low frequency (VLF) power of heart rate variability (HRV) is predictive of clinical prognosis in patients with congestive heart failure (CHF). METHOD AND RESULTS The study recruited 54 consecutive CHF patients with emergency admission because of exacerbation of pulmonary congestion. Holter monitoring was performed after improvement of pulmonary congestion. The frequency components of HRV were calculated in the frequency domain (VLF, low frequency (LF), high frequency (HF), total power (TP) and the ratio of LF to HF power). The left ventricular ejection fraction was calculated, and plasma brain natriuretic peptide (BNP) and norepinephrine were also measured at discharge. Within a mean follow-up period of 19.8 +/- 11.7 months, 18 patients experienced cardiovascular events; 7 patients died and 11 patients required rehospitalization because of worsening of CHF. In univariate analysis, diabetes mellitus (DM), BNP and New York Heart Association (NYHA) functional class were significant as risk factors for cardiac events. VLF power, LF power and TP were the strong predictors for cardiac events in HRV. In multivariate analysis, VLF power predicted cardiac events independently of LF power, TP, DM, BNP and NYHA functional class (chi-square=6.24, p=0.01). CONCLUSIONS VLF power is an independent risk predictor in patients with CHF.

[1]  T. Yandle,et al.  Biochemistry of natriuretic peptides , 1994, Journal of internal medicine.

[2]  G. Naccarelli,et al.  Congestive heart failure with normal systolic function. , 1984, The American journal of cardiology.

[3]  A. Tamura,et al.  Effect of preinfarction angina on heart rate variability in the early phase of the first anterior wall acute myocardial infarction. , 2002, Circulation journal : official journal of the Japanese Circulation Society.

[4]  M. Turiel,et al.  Power Spectral Analysis of Heart Rate and Arterial Pressure Variabilities as a Marker of Sympatho‐Vagal Interaction in Man and Conscious Dog , 1986, Circulation research.

[5]  K Koizumi,et al.  Effect of cardiac vagal and sympathetic nerve activity on heart rate in rhythmic fluctuations. , 1985, Journal of the autonomic nervous system.

[6]  D. Ferguson,et al.  Effects of heart failure on baroreflex control of sympathetic neural activity. , 1992, The American journal of cardiology.

[7]  D. Fukai,et al.  Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. , 1997, Circulation.

[8]  J. Fleiss,et al.  Efficient estimation of the heart period power spectrum suitable for physiologic or pharmacologic studies. , 1990, The American journal of cardiology.

[9]  A. DeMaria,et al.  Utility of B-Natriuretic Peptide in Detecting Diastolic Dysfunction , 2002 .

[10]  S. Yusuf,et al.  Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). , 1990, Circulation.

[11]  Kiyoshi Nakazawa,et al.  Autonomic imbalance as a property of symptomatic Brugada syndrome. , 2003, Circulation journal : official journal of the Japanese Circulation Society.

[12]  R. Tarazi,et al.  Assessment of parasympathetic control of heart rate by a noninvasive method. , 1984, The American journal of physiology.

[13]  P. Sleight,et al.  Physical activity influences heart rate variability and very-low-frequency components in Holter electrocardiograms. , 1996, Cardiovascular research.

[14]  J. Izzo,et al.  Validity and reliability of liquid chromatography with electrochemical detection for measuring plasma levels of norepinephrine and epinephrine in man. , 1981, Life sciences.

[15]  R Colombo,et al.  Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure. , 1999, Circulation.

[16]  I. Yamaguchi,et al.  Effects of linear ablation at the isthmus between the tricuspid annulus and inferior vena cava for atrial flutter on autonomic nervous activity: analysis of heart rate variability. , 2002, Circulation journal : official journal of the Japanese Circulation Society.

[17]  E. J. Brown,et al.  The effect of digoxin on mortality and morbidity in patients with heart failure. , 1997, The New England journal of medicine.

[18]  R. Prescott,et al.  Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart). , 1998, Circulation.

[19]  M. Packer Modulation of functional capacity and survival in congestive heart failure. Effects of activation of the sympathetic nervous system. , 1988, Postgraduate medicine.

[20]  W. Stevenson,et al.  Complex heart rate variability and serum norepinephrine levels in patients with advanced heart failure. , 1994, Journal of the American College of Cardiology.

[21]  J. Burnett,et al.  BNP: pathophysiological and potential therapeutic roles in acute congestive heart failure. , 1997, The American journal of physiology.

[22]  J. Fleiss,et al.  Frequency domain measures of heart period variability to assess risk late after myocardial infarction. , 1993, Journal of the American College of Cardiology.

[23]  J. Cohn,et al.  The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. , 1996, The New England journal of medicine.

[24]  T Seppänen,et al.  Impaired low-frequency oscillations of heart rate in patients with prior acute myocardial infarction and life-threatening arrhythmias. , 1995, The American journal of cardiology.

[25]  Richard J. Cohen,et al.  Estimation of heart rate power spectrum bands from real-world data: dealing with ectopic beats and noisy data , 1988, Proceedings. Computers in Cardiology 1988.

[26]  R. Cohen,et al.  Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. , 1981, Science.

[27]  G. Habib,et al.  Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings. , 2002, Circulation.

[28]  A. Tamura,et al.  Relationship between heart rate variability and left ventricular remodeling after reperfused first anterior wall acute myocardial infarction. , 2003, Circulation journal : official journal of the Japanese Circulation Society.

[29]  A. Malliani,et al.  Cardiovascular Neural Regulation Explored in the Frequency Domain , 1991, Circulation.

[30]  G D Pinna,et al.  Abnormal awake respiratory patterns are common in chronic heart failure and may prevent evaluation of autonomic tone by measures of heart rate variability. , 1997, Circulation.

[31]  H. Sostman,et al.  Intact systolic left ventricular function in clinical congestive heart failure. , 1985, The American journal of cardiology.

[32]  J. Cohn,et al.  Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. , 1984, The New England journal of medicine.

[33]  A. Richards,et al.  Assay of brain natriuretic peptide (BNP) in human plasma: evidence for high molecular weight BNP as a major plasma component in heart failure. , 1993, The Journal of clinical endocrinology and metabolism.

[34]  M. Naughton,et al.  Effects of nasal CPAP on sympathetic activity in patients with heart failure and central sleep apnea. , 1995, American journal of respiratory and critical care medicine.

[35]  RudolfBerger,et al.  B-Type Natriuretic Peptide Predicts Sudden Death in Patients With Chronic Heart Failure , 2002 .

[36]  P G Katona,et al.  Respiratory sinus arrhythmia: noninvasive measure of parasympathetic cardiac control. , 1975, Journal of applied physiology.

[37]  J. Fleiss,et al.  Frequency Domain Measures of Heart Period Variability and Mortality After Myocardial Infarction , 1992, Circulation.

[38]  D. Berman,et al.  Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[39]  G. Parati,et al.  Spectral analysis of blood pressure and heart rate variability in evaluating cardiovascular regulation. A critical appraisal. , 1995, Hypertension.

[40]  E F Cook,et al.  Comparative Reproducibility and Validity of Systems for Assessing Cardiovascular Functional Class: Advantages of a New Specific Activity Scale , 1981, Circulation.